2019
DOI: 10.1016/j.cgh.2019.01.025
|View full text |Cite
|
Sign up to set email alerts
|

Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
39
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(45 citation statements)
references
References 17 publications
2
39
0
Order By: Relevance
“…There was a strong power in machine learning approach on constructing new scoring system based on existing clinical indicators. Despite some scoring systems for cancer have been created and validated by the novel method of machine learning [35], the evidence of scoring system based on inflammation biomarkers for gastric cancer is still lacking and elusive. Thus, more studies using the novel method of machine learning are needed to discover more effective biomarker in gastric cancer.…”
Section: Discussionmentioning
confidence: 99%
“…There was a strong power in machine learning approach on constructing new scoring system based on existing clinical indicators. Despite some scoring systems for cancer have been created and validated by the novel method of machine learning [35], the evidence of scoring system based on inflammation biomarkers for gastric cancer is still lacking and elusive. Thus, more studies using the novel method of machine learning are needed to discover more effective biomarker in gastric cancer.…”
Section: Discussionmentioning
confidence: 99%
“…Sixteen studies focused on hepatology. Of those studies, 7 aimed to detect fibrosis associated with viral hepatitis, [124][125][126][127][128][129][130] 6 developed AI strategies to detect nonalcoholic fatty liver disease, [131][132][133][134][135][136] 2 were developed to identify patients with esophageal varices, 137,138 and 1 to assess patients with chronic liver disease of any cause. 139 Thirteen studies used data from electronic medical records and/or biologic features to build the algorithms and 3 studies used data from elastography.…”
Section: Liver and Pancreatobiliary Disordersmentioning
confidence: 99%
“…The prevalence of EV in cirrhotic patients is approximately 60-80%, and the 1-year rate of first variceal hemorrhage is approximately 12% [5% for lowrisk varices and 15% for high-risk varices (HRV)] [1][2][3]. The mortality of variceal bleeding ranges from 15 to 55% [4]. Esophagogastroduodenoscopy (EGD) is usually recommended to identify those at risk of bleeding who should undergo prophylaxis treatment in patients with established cirrhosis [5].…”
Section: Introductionmentioning
confidence: 99%